✦ LIBER ✦

Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancer

✍ Scribed by VEDANG MURTHY; ANDREW R. NORMAN; MEHDI SHAHIDI; CHRISTOPHER C. PARKER; ALAN HORWICH; ROBERT A. HUDDART; ARSHA BANGE; DAVID P. DEARNALEY

Book ID: 109052278
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 124 KB
Volume: 97
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2006.06013.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

INDIVIDUAL VARIATIONS OF SERUM TESTOSTER

INDIVIDUAL VARIATIONS OF SERUM TESTOSTERONE IN PATIENTS WITH PROSTATE CANCER RECEIVING ANDROGEN-DEPRIVATION THERAPY

✍ Anthony Koupparis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Individual variations of serum testoster

Individual variations of serum testosterone in patients with prostate cancer receiving androgen deprivation therapy

✍ Juan Morote; Jacques Planas; Carlos Salvador; Carles X. Raventós; Roberto Catalá 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Comparative risk-adjusted mortality outc

Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

✍ Matthew R. Cooperberg; Andrew J. Vickers; Jeanette M. Broering; Peter R. Carroll 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB 👁 2 views

Comparative risk-adjusted mortality outc

Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

✍ Michael Froehner 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

Comparative risk-adjusted mortality outc

Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

✍ Axel Madlung; Mathew Simcock; Pirus Ghadjar 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Results of a Prospective Phase 2 Trial With great interest we read the article by Brown et al, who reported the results of a phase 2 study using gemcitabine and cisplatin in patients with advanced endometrial cancer. 1 Although we recognize the reported impressive activity of this regimen, we b

Erratum: Comparative risk-adjusted morta

Erratum: Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

✍ Matthew R. Cooperberg; Andrew J. Vickers; Jeanette M. Broering; Peter R. Carroll 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views